Endometrial cancer

• Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( R … Pending
  2024-519818-31-01 5 "Endometrial Cancer Advanced, Recurrent, Metastatic, or Prima"
• A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, a … Pending
  2025-523590-42-00 7 "Locally Advanced or Metastatic Solid Tumors"
• A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043) Recruiting
  2025-524160-38-00 5 2026-05-12 "Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI-H/dMM"
• A clinical study of the anti-cancer effects of an investigational therapy or chemotherapy in patients with recurring uterine cancer Recruiting
  2023-507525-42-00 5 2025-12-23
• A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab vs Chemotherapy plus Pembrolizumab as First-Line Treatment o … Recruiting
  2023-508056-19-00 5 2025-10-02 "HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient"
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 Recruiting
  2023-504445-31-00 4 2024-09-19 "Carcinoma, Head and Neck"
• A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors Recruiting
  2022-502654-14-00 4 2023-09-11
• A Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors Recruiting
  2023-510275-64-00 9 2023-05-31 "Hepatocellular carcinoma, colorectal cancer, endometrial can"
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma Recruiting
  2025-524542-10-00 4 2026-04-14
• A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors Recruiting
  2025-524334-26-01 1 2026-03-26 "Advanced or metastatic solid tumors"
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known t … Recruiting
  2025-522613-26-00 7 2026-03-13 "Advanced Solid Cancers"
• A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting
  2024-516551-41-00 4 2026-03-06 "Patients with HER2-expressing solid tumors"
• A Phase 1 Study for ZW191 in Participants with Solid Tumors Recruiting
  2024-512299-37-00 1 2026-02-18 "Advanced solid tumors"
• A Phase 1a/1b, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity … Recruiting
  2025-523165-19-00 1 2026-02-10 "Advanced, metastatic or unresectable solid tumors"
• Phase II clinical trial to assess the efficacy of dostarlimab as neoadjuvant therapy in patients with MMRd/MSI-H stage II-III endometrial ca … Recruiting
  2024-512021-81-00 4 2025-12-01 "MMRd/MSI-H stage II-III endometrial cancer"
• An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination with Different Treatment Regimens … Recruiting
  2024-517432-21-00 4 2025-05-30 "Gynecological Cancers"
• First -in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors Recruiting
  2023-507937-14-00 7 2025-03-25 "Metastatic Solid Tumor"
• A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so … Recruiting
  2024-517419-62-00 4 2025-02-28 "HER2 mutation"
• Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting
  2023-509632-26-00 9 2025-02-11 "Recurrent or Metastatic Solid Tumors (endometrial cancer (EC"
• Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers Recruiting
  2023-509767-25-00 1 2024-11-07 "Advanced PRAME Positive Cancers"
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE) Recruiting
  2023-504251-27-00 7 2024-05-27 "Locally Advanced or Metastatic Solid Tumors Harboring a TP53"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CD … Recruiting
  2023-506888-34-00 1 2024-05-22 "Advanced or metastatic solid tumors including hormone recept"
• Trial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced … Recruiting
  2024-517363-24-00 4 2024-02-16 "Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid"
• Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting
  2023-506604-18-00 1 2024-02-14 "Triple negative breast cancer"

Showing 1–24 of 42 trials